2018
DOI: 10.1128/aac.00720-18
|View full text |Cite
|
Sign up to set email alerts
|

Emergence and Within-Host Genetic Evolution of Methicillin-Resistant Staphylococcus aureus Resistant to Linezolid in a Cystic Fibrosis Patient

Abstract: Methicillin-resistant Staphylococcus aureus (MRSA) infection has increased in recent years among cystic fibrosis (CF) patients. Linezolid (LZD) is one of the antistaphylococcal antibiotics widely used in this context. Although LZD resistance is rare, it has been described as often associated with long-term treatments. Thirteen MRSA strains isolated over 5 years from one CF patient were studied for LZD resistance emergence and subjected to whole-genome sequencing (WGS). Resistance emerged after three 15-day LZD… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

4
25
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 26 publications
(29 citation statements)
references
References 56 publications
4
25
0
Order By: Relevance
“…Even though establishing relationships between mutations and the related phenotypic change in resistance was not the aim of this study, differences in AMR profiles among isolates have been associated with previously reported point mutations in the target genes of the antimicrobials and the acquisition of Tn4001 and Tn4001-like elements [43]. In agreement with the findings of Rouard et al [53], the level of resistance to linezolid in isolates recovered from patient 3 showed a possible correlation with the percentage of reads harbouring the G2576T mutation in the 23S rRNA gene, and thus with the number of 23S rRNA gene copies carrying this mutation. In addition to the differences in AMR profiles, we also detected decreases in the growth rates of sequential isolates in three out of four patients, when compared to the first isolate (Fig.…”
Section: Discussionsupporting
confidence: 90%
See 2 more Smart Citations
“…Even though establishing relationships between mutations and the related phenotypic change in resistance was not the aim of this study, differences in AMR profiles among isolates have been associated with previously reported point mutations in the target genes of the antimicrobials and the acquisition of Tn4001 and Tn4001-like elements [43]. In agreement with the findings of Rouard et al [53], the level of resistance to linezolid in isolates recovered from patient 3 showed a possible correlation with the percentage of reads harbouring the G2576T mutation in the 23S rRNA gene, and thus with the number of 23S rRNA gene copies carrying this mutation. In addition to the differences in AMR profiles, we also detected decreases in the growth rates of sequential isolates in three out of four patients, when compared to the first isolate (Fig.…”
Section: Discussionsupporting
confidence: 90%
“…High phenotypic and/or genotypic diversity, including antimicrobial susceptibility, among S. aureus sequential isolates recovered from patients with CF as well as among variants from the same sputum sample have been described previously [ 5,6,48,52,53]. Even though establishing relationships between mutations and the related phenotypic change in resistance was not the aim of this study, differences in AMR profiles among isolates have been associated with previously reported point mutations in the target genes of the antimicrobials and the acquisition of Tn4001 and Tn4001-like elements [43].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Prior studies tried to assess the number of SNPs accumulating over time, but mostly under selective conditions. Rouard et al (2018) calculated that during selection for linezolid resistance an expected 17–93 mutations should accumulate per genome per year. A more global calculation using a significantly larger strain collection resulted in average number of less than 10 SNPs per genome per year (Harris et al, 2010).…”
Section: Discussionmentioning
confidence: 99%
“…But those step-specific adaptations may also trade off with each other: the pathogenic strains that are successful and dominant at the initiation of the disease might differ from those that are successful and dominant at a given advanced step of an infection. Within-host evolution has been described in many human bacterial diseases, such as those associated with Helicobacter pylori (4), Staphyloccocus aureus (5), or the causative agent of melioidosis, Burkholderia pseudomallei (6), and the genetic basis behind the adaptations has stimulated a lot of interest. However, the studied adaptations are generally focused on antibiotic resistance and rarely on the adaptation to the environment given by the host, and the potential trade-offs hindering adaptations to each step of the infection, especially within the host, are rarely considered (7).…”
mentioning
confidence: 99%